about ers

ERS Genomics was formed to provide broad access to the foundational CRISPR-Cas9 intellectual property held by Dr. Emmanuelle Charpentier. Licenses are available in multiple fields of use.  LEARN MORE


“CRISPR” refers to clustered regularly interspaced short palindromic repeats. The CRISPR platform technology utilizes a molecular complex comprised of the protein Cas9 together with one or more guide RNAs which binds to the genome in living cells at any desired locations. LEARN MORE